Literature DB >> 26974306

Critical Care in Human Immunodeficiency Virus-Infected Patients.

Kathleen M Akgün1, Robert F Miller2.   

Abstract

Intensive care unit (ICU) survival has been improved significantly for HIV-infected patients since the advent of antiretroviral therapy (ART). Non-AIDS conditions account for the majority of ICU admission diagnoses in areas with access to ART. However, opportunistic infections such as Pneumocystis jirovecii pneumonia still account for a significant proportion of ICU admissions, particularly in newly diagnosed HIV-infected patients, and are associated with increased ICU mortality. We discuss risk factors and outcomes for HIV-infected admitted to the ICU in the current ART era. We review the changing patterns in ICU admission diagnoses over time and how common ICU conditions are managed in HIV-infected compared with uninfected patients. We next address issues specific to the care for HIV-infected patients in the ICU, focusing on immune reconstitution inflammatory syndrome, ART continuation or initiation, and some common and potentially life-threatening ART-associated toxicities. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26974306     DOI: 10.1055/s-0036-1572561

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  3 in total

Review 1.  Management of HIV-infected patients in the intensive care unit.

Authors:  François Barbier; Mervin Mer; Piotr Szychowiak; Robert F Miller; Éric Mariotte; Lionel Galicier; Lila Bouadma; Pierre Tattevin; Élie Azoulay
Journal:  Intensive Care Med       Date:  2020-02-03       Impact factor: 17.440

2.  CD4+ cell count and outcomes among HIV-infected compared with uninfected medical ICU survivors in a national cohort.

Authors:  Kathleen M Akgün; Supriya Krishnan; Adeel A Butt; Cynthia L Gibert; Christopher J Graber; Laurence Huang; Margaret A Pisani; Maria C Rodriguez-Barradas; Guy W Soo Hoo; Amy C Justice; Kristina Crothers; Janet P Tate
Journal:  AIDS       Date:  2021-11-15       Impact factor: 4.177

3.  Extra Corporeal Membrane Oxygenation in the Treatment of Human Immunodeficiency Virus-Related P. jirovecii Pneumonia.

Authors:  Sara Lacerda Pereira; Elsa Branco; Ana Sofia Faustino; Paulo Figueiredo; António Sarmento; Lurdes Santos
Journal:  Infect Dis Rep       Date:  2021-12-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.